Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Supportive Therapy for Adherence to ART(STAART)

This study has been completed.
Sponsor:
Collaborator:
Ontario HIV Treatment Network
Information provided by:
Ottawa Hospital Research Institute
ClinicalTrials.gov Identifier:
NCT00212940
First received: September 13, 2005
Last updated: July 25, 2007
Last verified: July 2007

September 13, 2005
July 25, 2007
October 2000
Not Provided
psycho-educational intervention can help people living with HIV handle the changes of treatment adherence
Not Provided
Complete list of historical versions of study NCT00212940 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Supportive Therapy for Adherence to ART(STAART)
Increasing Patient Adherence to HIV Medications: A Prospective Intervention Study

The purpose of this study is to determine whether a psycho-educational intervention can help people living with HIV handle the changes of treatment adherence.

Participants will be randomly assigned to one of two study groups:

  • Group 1: participants in this group will engage in weekly psycho-educational sessions with an HIV therapist for four weeks prior to starting their regimens. The sessions will cover topics such as becoming active in treatment care, improving coping abilities and developing skills for treatment adherence. They will also involve questionnaires and readings.
  • Group 2 (the control group):participants in this group will simply receive their regular treatment regimens.
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
HIV Infections
Behavioral: Supportive Therapy for Adherence to ART (behavior)
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
112
September 2006
Not Provided

Inclusion Criteria:

  • be at least 18 years of age
  • have viral load above 500 copies/ml
  • not be currently on HAART
  • be able to read and speak English/French

Exclusion Criteria:

  • current Substance Abuse
  • actively psychotic or suicidal
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00212940
1999565-01H, CIHR app# 1262000 ICE:
Not Provided
Not Provided
Ottawa Hospital Research Institute
Ontario HIV Treatment Network
Principal Investigator: William Cameron, MD OHRI
Ottawa Hospital Research Institute
July 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP